🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Haolin Shen

Howard Hughes Medical Institute

ORCID: 0000-0003-1550-2831

Also affiliated with University of California, San Francisco, University of San Francisco

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research(2022)10.1093/nar/gkac979
Top 19%
1.0DataRank
Top 19%46 citations

Arpad Danos, Jason Saliba, Joshua F. McMichael, Adam Coffman, Susanna Kiwala +60 more

Papers

Driven by 7 papers — median percentile 81. Top paper: “CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase”.

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research(2022)10.1093/nar/gkac979
Top 19%
1.0DataRank
Top 19%46 citations

Arpad Danos, Jason Saliba, Joshua F. McMichael, Adam Coffman, Susanna Kiwala +60 more

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Genetics in Medicine(2022)10.1016/j.gim.2022.01.001
N/A
0.829DataRank · unranked
250 citations

Malachi Griffith, Arpad Danos, Beth A. Pitel, Subha Madhavan, Xue‐Lu Liu +42 more

Central control of dynamic gene circuits governs T cell rest and activation

Nature(2024)10.1038/s41586-024-08314-y
N/A
0.494DataRank · unranked
26 citations

Jennifer M. Umhoefer, Nadia Arang, Sivakanthan Kasinathan, Jacob W. Freimer, Zachary Steinhart +18 more

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.28.534561
N/A
0.104DataRank · unranked
1 citations

Timothy H.-P. Chen, Bryan Fisk, Haolin Shen, Matthew Mosior, Zachary L. Skidmore +6 more

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

iScience(2023)10.1016/j.isci.2023.107937
N/A
0DataRank · unranked
6 citations

Timothy H.-P. Chen, Bryan Fisk, Haolin Shen, Matthew Mosior, Zachary L. Skidmore +6 more

Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregation

Nature Immunology(2024)10.1038/s41590-024-01976-w
N/A
0DataRank · unranked
9 citations

Tiantian Liu, Pritesh Desai, Stephen T. Ferris, Sun Kyung Kim, Haolin Shen +9 more

Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine

The Journal of Experimental Medicine(2025)10.1084/jem.20250887
N/A
0DataRank · unranked
2 citations

Haolin Shen, Ying Xu, Jinping An, Jason G. Cyster, H.K. Tam